Tom Godfrey
Stock Analyst at Ord Minnett
(4.81)
# 502
Out of 5,005 analysts
140
Total ratings
50.5%
Success rate
40.1%
Average return
Main Sectors:
Stocks Rated by Tom Godfrey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: EIQ Echo IQ Limited | Reiterated: Buy | $2.00 → $1.55 | $0.54 | +187.04% | 9 | Sep 9, 2026 | |
| ASX: REG Regis Healthcare Limited | Downgraded: Hold | $8.40 → $6.00 | $4.48 | +33.93% | 31 | Sep 3, 2026 | |
| ASX: MVF Monash IVF Group Limited | Reiterated: Buy | $0.85 | $0.74 | +14.86% | 12 | Sep 1, 2026 | |
| ASX: SIG Sigma Healthcare Limited | Reiterated: Buy | $3.40 | $2.56 | +32.81% | 12 | Aug 28, 2026 | |
| ASX: TRJ Trajan Group Holdings Limited | Reiterated: Buy | $0.90 → $0.60 | $0.26 | +130.77% | 7 | Aug 28, 2026 | |
| ASX: PGC Paragon Care Limited | Reiterated: Buy | $0.33 → $0.30 | $0.14 | +114.29% | 9 | Aug 27, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Reiterated: Buy | $3.20 → $3.30 | $2.18 | +51.38% | 15 | Aug 26, 2026 | |
| NZE: EBO EBOS Group Limited | Reiterated: Buy | $34.85 → $32.36 | $19.36 | +67.17% | 8 | Aug 20, 2026 | |
| ASX: ACL Australian Clinical Labs Limited | Reiterated: Hold | $2.20 → $2.60 | $2.78 | -6.47% | 10 | Aug 18, 2026 | |
| ASX: VFY Vitrafy Life Sciences Limited | Reiterated: Buy | $4.20 → $5.00 | $3.43 | +45.77% | 6 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3.00 | $3.99 | -24.81% | 12 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.05 → $0.02 | $0.01 | +300.00% | 9 | May 12, 2026 |
Echo IQ Limited
Sep 9, 2026
Reiterated: Buy
Price Target: $2.00 → $1.55
Current: $0.54
Upside: +187.04%
Regis Healthcare Limited
Sep 3, 2026
Downgraded: Hold
Price Target: $8.40 → $6.00
Current: $4.48
Upside: +33.93%
Monash IVF Group Limited
Sep 1, 2026
Reiterated: Buy
Price Target: $0.85
Current: $0.74
Upside: +14.86%
Sigma Healthcare Limited
Aug 28, 2026
Reiterated: Buy
Price Target: $3.40
Current: $2.56
Upside: +32.81%
Trajan Group Holdings Limited
Aug 28, 2026
Reiterated: Buy
Price Target: $0.90 → $0.60
Current: $0.26
Upside: +130.77%
Paragon Care Limited
Aug 27, 2026
Reiterated: Buy
Price Target: $0.33 → $0.30
Current: $0.14
Upside: +114.29%
Integral Diagnostics Limited
Aug 26, 2026
Reiterated: Buy
Price Target: $3.20 → $3.30
Current: $2.18
Upside: +51.38%
EBOS Group Limited
Aug 20, 2026
Reiterated: Buy
Price Target: $34.85 → $32.36
Current: $19.36
Upside: +67.17%
Australian Clinical Labs Limited
Aug 18, 2026
Reiterated: Hold
Price Target: $2.20 → $2.60
Current: $2.78
Upside: -6.47%
Vitrafy Life Sciences Limited
Aug 14, 2026
Reiterated: Buy
Price Target: $4.20 → $5.00
Current: $3.43
Upside: +45.77%
Jun 3, 2026
Reiterated: Sell
Price Target: $3.00
Current: $3.99
Upside: -24.81%
May 12, 2026
Reiterated: Buy
Price Target: $0.05 → $0.02
Current: $0.01
Upside: +300.00%